In a groundbreaking Australian study, researchers are testing a testosterone cream on a group of women in their later reproductive years to address issues with low libido.

Currently, women in their 30s and 40s who are troubled by this challenge lack available treatment options.

“It’s a taboo subject, so you sort of suffer in silence a little bit,” shared Sarah Eglinton, 52, who took part in a similar testosterone trial previously.

Reflecting on her mid-30s, Sarah believed her exhaustion was just a typical part of raising young children.

“I wasn’t aware that during that time, my testosterone levels were beginning to decline and would continue to do so,” she explained.

According to specialists, approximately 10% of premenopausal women in their later reproductive years experience a reduction in sexual desire.

That number doubles to nearly 20 per cent in perimenopause.

“In Australia, right now, there is no specific treatment for low libido that has been approved for premenopausal and perimenopausal women,” said Professor Susan Davis, head of the Women’s Health Research Program at Monash University.

Previous work by the Monash University team was pivotal in having testosterone cream approved in 2022 for women after menopause.

“This really has been a game changer for a lot of women,” Davis said.

That same formulation, which involves rubbing a small amount on the thigh so it can dissolve into the skin, will be used for the new study.

It’s currently enrolling 260 women who live in Victoria, aged between 35 and 50, who are not yet in menopause.

NEVER MISS A STORY: Get your breaking news and exclusive stories first by following us across all platforms.